Bone marrow transplantation in apolipoprotein E-deficient mice: Effect of ApoE gene dosage on serum lipid concentrations, (β)VLDL catabolism, and atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 11, 1997, Pages 3117-3126

  Van Eck, Miranda ^a   Herijgers, Nicole ^a   Yates, John ^b   Pearce, Nigel J ^b   Hoogerbrugge, Peter M ^c   Groot, Pieter H E ^b   Van Berkel, Theo J C ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b GLAXOSMITHKLINE   (United Kingdom)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ApoE deficiency; Atherosclerosis; Gene transfer; Macrophages; VLDL

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; LIPID; LIPOPROTEIN RECEPTOR; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; GENE DOSAGE; GENE TRANSFER; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA TYPE 3; HYPERTRIGLYCERIDEMIA; KUPFFER CELL; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031470817     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.11.3117     Document Type: Article

References (9)

1. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988;240:622-630.
2. Moestrup SK. The α2-macroglobulin receptor and epithelial glycoprotein-330: two giant receptors mediating endocytosis of multiple ligands. Biochim Biophys Acta. 1994;1197:197-213.
3. Krieger M, Herz J. Structures and functions of multiligand receptors: macrophage scavenger receptors and LDL receptorrelated protein (LRP). Annu Rev Biochem. 1994;62:601-637.
4. Rail SC Jr., Mahley RW. The role of apolipoprotein E genetic variants in lipoprotein disorders. J Int Med. 1992;231:653-659.
5. Havekes L, De Wit E, Gevers Leuven J, Klasen E, Utermann G, Weber W, Beisiegel U. Apolipoprotein E3-Leiden: a new variant of human apolipoprotein E, associated with familial type III hyperlipoproteinemia. Hum Genet. 1986;73:157-163.
6. Horie Y, Fazio S, Westerlund JR, Weisgraber KH, Rail SC Jr. The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia. J Biol Chem. 1992;267:1962-1968.
7. Ghiselli G, Schaefer EJ, Gascon P, Brewer HB Jr. Type III hyperlipoproteinemia associated with apolipoprotein E deficiency. Science. 1981;214:1239-1241.
8. Schaefer EJ, Gregg RE, Ghiselli G, Forte TM, Ordovas JM, Zech LA, Brewer HB, Jr. Familial apolipoprotein E deficiency. J Clin Invest. 1986;78:1206-1219.
9. Cladaras C, HadzopouIou-CIadaras M, Felber BK, Pavlakis G, Zannis VI. The molecular basis of familial apoE deficiency: an acceptor splice site mutation in the third intron of the deficient apoE gene. J Biol Chem. 1987;262:2310-2315.